Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 9,491	$ 8,288
Fixed maturity securities (amortized cost of $25,773 and $25,879; allowance for credit losses of $21 and $6)	25,884	25,201
Equity securities	740	1,192
Premium receivables	10,073	8,011
Self-funded receivables	5,162	5,044
Other receivables	6,307	6,016
Other current assets	5,344	4,700
Assets held for sale	0	490
Total current assets	63,001	58,942
Long-term investments:
Fixed maturity securities (amortized cost of $1,116 and $1,049; allowance for credit losses of $0 and $0)	1,121	1,035
Other invested assets	10,839	9,749
Property and equipment, net	4,679	4,652
Goodwill	28,344	28,277
Other intangible assets	11,200	12,094
Other noncurrent assets	2,310	2,140
Total assets	121,494	116,889
Current liabilities:
Medical claims payable	17,084	15,746
Other policyholder liabilities	3,632	4,204
Unearned income	1,493	1,508
Accounts payable and accrued expenses	7,322	6,927
Short-term borrowings	150	365
Current portion of long-term debt	1,099	1,649
Other current liabilities	10,255	10,029
Liabilities held for sale	0	153
Total current liabilities	41,035	40,581
Long-term debt, less current portion	30,797	29,218
Reserves for future policy benefits	145	190
Deferred tax liabilities, net	2,110	2,148
Other noncurrent liabilities	3,381	3,326
Total liabilities	77,468	75,463
Commitments and Contingencies—Note 14
Shareholders’ equity
Preferred stock, without par value, shares authorized - 100,000,000; shares issued and outstanding - none	0	0
Common stock, par value $0.01, shares authorized - 900,000,000; shares issued and outstanding - 220,723,898 and 227,479,695	2	2
Additional paid-in capital	8,938	8,911
Retained earnings	35,393	33,549
Accumulated other comprehensive loss	(451)	(1,147)
Total shareholders’ equity	43,882	41,315
Noncontrolling interests	144	111
Total equity	44,026	41,426
Total liabilities and equity	$ 121,494	$ 116,889